Vermont S 22: An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Status: Senate Message, signed by Governor June 7, 2021 (as of 2021-05-21)

State: Vermont · Session: 2021-2022 · Bill: S 22

Sponsors: Virginia Lyons, Richard McCormack

View Vermont S 22 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.